Skip To Main Content
Charles Armitstead on Muck Rack

Charles Armitstead

As seen in: ADVFN
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Charles Armitstead’s profile

Articles by Charles Armitstead

Hikma Pharmaceuticals Plc Hikma appoints new President of Injectables

|
By Susan Ringdal, Charles Armitstead
| ADVFN
Hikma Pharmaceuticals (LSE:HIK) Intraday Stock Chart Wednesday 9 August 2023 TIDMHIK RNS Number : 7127I Hikma Pharmaceuticals Plc 09 August 2023 Hikma appoints new President of Injectables business London, 9 August 2023 - Hikma Pharmaceuticals PLC and its subsidiaries ('Hikma' or 'Group'), the multinational pharmaceutical company, announce that Dr. Bill Larkins has been appointed President of its Injectables business, effective 1 September 2023.
Open in Who Shared View Duplicates (10) Issue with article?

Hikma Pharmaceuticals Plc Half-year Report

|
By Susan Ringdal, Charles Armitstead
| ADVFN
Hikma Pharmaceuticals (LSE:HIK) Intraday Stock Chart Thursday 3 August 2023 TIDMHIK RNS Number : 1402I Hikma Pharmaceuticals Plc 03 August 2023 Hikma delivers strong H1 performance and raises Generics guidance Growth in all three businesses and across all geographies London, 3 August 2023 - Hikma Pharmaceuticals PLC and its subsidiaries ('Hikma' or 'Group'), the multinational pharmaceutical company, today reports its interim results for the six months ended 30 June 2023.
Open in Who Shared Issue with article?

Hikma Pharmaceuticals Plc Final Results

|
By - Full-year dividend, Susan Ringdal, Charles Armitstead, As at As
| ADVFN
Share Name Share Symbol Market Type Share ISIN Share Description Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 78.50 4.48% 1,832.00 1,830.50 1,835.00 1,842.50 1,763.50 1,764.50 58,997 08:43:56 Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) Pharmaceuticals & Biotechnology 1,887.9 402.3 134.8 12.1 4,241 Hikma...
Open in Who Shared Issue with article?
Show More